Levin Capital Strategies’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,000
| Closed | -$377K | – | 236 |
|
|
2024
Q3 | $377K | Buy |
+6,000
| New | +$350K | 0.04% | 146 |
|
|
2023
Q4 | – | Sell |
-46,279
| Closed | -$3.23M | – | 267 |
|
|
2023
Q3 | $3.23M | Sell |
46,279
-16,146
| -26% | -$1.14M | 0.38% | 53 |
|
|
2023
Q2 | $4.32M | Buy |
62,425
+30,052
| +93% | +$2.14M | 0.49% | 42 |
|
|
2023
Q1 | $2.41M | Sell |
32,373
-3,529
| -10% | -$296K | 0.3% | 59 |
|
|
2022
Q4 | $3.35M | Buy |
35,902
+31,847
| +785% | +$3.07M | 0.45% | 52 |
|
|
2022
Q3 | $387K | Hold |
4,055
| – | – | 0.05% | 134 |
|
|
2022
Q2 | $376K | Hold |
4,055
| – | – | 0.04% | 159 |
|
|
2022
Q1 | $410K | Hold |
4,055
| – | – | 0.04% | 180 |
|
|
2021
Q4 | $418K | Hold |
4,055
| – | – | 0.04% | 186 |
|
|
2021
Q3 | $344K | Hold |
4,055
| – | – | 0.03% | 215 |
|
|
2021
Q2 | $338K | Sell |
4,055
-2,500
| -38% | -$205K | 0.03% | 211 |
|
|
2021
Q1 | $493K | Buy |
6,555
+2,500
| +62% | +$182K | 0.05% | 146 |
|
|
2020
Q4 | $277K | Sell |
4,055
-2,500
| -38% | -$163K | 0.03% | 218 |
|
|
2020
Q3 | $383K | Buy |
6,555
+2,500
| +62% | +$156K | 0.05% | 163 |
|
|
2020
Q2 | $263K | Hold |
4,055
| – | – | 0.04% | 142 |
|
|
2020
Q1 | $241K | Hold |
4,055
| – | – | 0.04% | 124 |
|
|
2019
Q4 | $301K | Sell |
4,055
-4,500
| -53% | -$316K | 0.03% | 150 |
|
|
2019
Q3 | $540K | Buy |
8,555
+1,500
| +21% | +$88.9K | 0.06% | 109 |
|
|
2019
Q2 | $384K | Buy |
7,055
+500
| +8% | +$26.9K | 0.04% | 132 |
|
|
2019
Q1 | $354K | Sell |
6,555
-965,854
| -99% | -$59.6M | 0.04% | 130 |
|
|
2018
Q4 | $63.7M | Buy |
972,409
+964,854
| +12,771% | +$72M | 1.4% | 26 |
|
|
2018
Q3 | $595K | Buy |
7,555
+3,500
| +86% | +$250K | 0.01% | 172 |
|
|
2018
Q2 | $261K | Sell |
4,055
-4,055
| -50% | -$267K | ﹤0.01% | 233 |
|
|
2018
Q1 | $505K | Hold |
8,110
| – | – | 0.01% | 188 |
|
|
2017
Q4 | $588K | Hold |
8,110
| – | – | 0.01% | 186 |
|
|
2017
Q3 | $660K | Sell |
8,110
-790,930
| -99% | -$62.6M | 0.01% | 178 |
|
|
2017
Q2 | $64.3M | Buy |
799,040
+790,930
| +9,753% | +$62.5M | 1.12% | 28 |
|
|
2017
Q1 | $637K | Sell |
8,110
-515,686
| -98% | -$41.2M | 0.01% | 183 |
|
|
2016
Q4 | $41.3M | Buy |
523,796
+515,686
| +6,359% | +$41.7M | 0.71% | 39 |
|
|
2016
Q3 | $722 | Sell |
8,110
-1,000
| -11% | -$94.4K | 0.01% | 200 |
|
|
2016
Q2 | $872K | Buy |
9,110
+1,000
| +12% | +$99.7K | 0.02% | 177 |
|
|
2016
Q1 | $841K | Hold |
8,110
| – | – | 0.02% | 188 |
|
|
2015
Q4 | $793K | Hold |
8,110
| – | – | 0.01% | 218 |
|
|
2015
Q3 | $782K | Hold |
8,110
| – | – | 0.01% | 213 |
|
|
2015
Q2 | $851K | Sell |
8,110
-1,785
| -18% | -$182K | 0.01% | 223 |
|
|
2015
Q1 | $1.02M | Buy |
9,895
+7,600
| +331% | +$769K | 0.02% | 218 |
|
|
2014
Q4 | $221K | Buy |
+2,295
| New | +$202K | ﹤0.01% | 358 |
|
Other funds holding CVS
Levin Capital Strategies's CVS Position: Q4 2024 in Review
Levin Capital Strategies sold out of CVS Health (CVS) in Q4 2024, closing a stake of 6,000 shares — an estimated $377K sold.
Levin Capital Strategies first reported a position in CVS in Q4 2014 and held it in 37 quarters. The position peaked at $64.3M in Q2 2017. 1,669 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Levin Capital Strategies reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
- Levin Capital Strategies sold 6,000 CVS Health shares in Q4 2024, an estimated $377K.
- Levin Capital Strategies first reported a position in CVS Health in Q4 2014 and held it in 37 quarters.
- Levin Capital Strategies's CVS Health position peaked at $64.3M in Q2 2017.
- 1,669 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Levin Capital Strategies's 13F filing for Q4 2024, filed 5 Feb 2025.